Image default

Expert’s recommendation for the treatment of lung cancer and how it starts?

Experts recommend a variety of treatments for lung cancer, depending on the type and stage of the disease. Treatment options may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and/or clinical trials. The most appropriate treatment plan for an individual patient is determined by their healthcare team, taking into account the patient’s overall health, the type and stage of cancer, and the patient’s preferences. Treatment for lung cancer may also include supportive care to help manage symptoms and side effects.

How does lung cancer begin? 

Lung cancer is a serious and potentially life-threatening condition that can develop when abnormal cells in the lungs grow and divide uncontrollably. It is typically caused by prolonged exposure to carcinogens, such as tobacco smoke, asbestos, and radon gas. Other risk factors include a family history of lung cancer, a weakened immune system, and a history of radiation therapy. Early detection is key to successful treatment, so it is important to be aware of the signs and symptoms of lung cancer and to seek medical attention if any of these are present.

Why is ceritinib prescribed for lung cancer?

Ceritinib is a medicine used to treat certain types of non-small cell lung cancer. It works by blocking certain proteins that help cancer cells grow and spread. By blocking these proteins, ceritinib can help slow down the growth and spread of cancer cells, allowing patients to live longer and healthier lives. Additionally, ceritinib 150mg Capsule has been found to be effective in treating certain types of brain tumors, as well as other types of cancer. This medicine is an important tool in the fight against cancer, providing hope to those who are suffering from this devastating disease.

New research on the efficacy of ceritinib

Ceritinib is an effective and safe first-line treatment for Asian patients with advanced ALK-rearranged non-small cell lung cancer (NSCLC). The progression-free survival (PFS) results, assessed by both BIRC and investigators, were in line with those of the overall ASCEND-4 study population. Ceritinib also shows a high intracranial activity that was consistent with the overall population. Ceritinib is a cost-effective and efficacious treatment option for Asian patients with advanced ALK-rearranged NSCLC in the first-line setting.

Also, Read- Pediamte

About Author

Related posts

Saffron Has Several Health Benefits For Men


Post-treatment Tips/Follow-up Care for Oral Cancer Patients


Gluten Free Atta For Celiac Disease


Leave a Comment